- Cat. No.
- A16192
CID5721353
CID5721353 is a B-Cell Lymphoma 6 Inhibitor (BCL6 inhibitor).
Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
Bcl-2 family inhibitors act on B-cell lymphoma 2 (Bcl-2) proteins that control the mitochondrial pathway of apoptosis. In 1988 Bcl-2 was shown to promote survival of hematopoietic cells and to cooperate with c-myc in immortalizing pre-B cells. Antiapoptotic members such as Bcl-2, B-cell lymphoma-extra large (Bcl-xL) and myeloid cell leukemia 1 (Mcl-1) restrain proapoptotic partners such as Bcl-2-associated X protein (Bax). Small molecules that mimic Bcl-2 homology 3 (BH3) domains occupy their binding groove and release these partners. ABT-737, reported in 2005, and navitoclax inhibit Bcl-2, Bcl-xL and Bcl-w. Venetoclax, first described in 2013 as ABT-199, is selective for Bcl-2, while A-1155463 prefers Bcl-xL. BAM 7 works in the opposite direction by activating Bax directly.
CID5721353 is a B-Cell Lymphoma 6 Inhibitor (BCL6 inhibitor).
Synonyms: ApoG2
Apogossypolone is a nonpeptidic small-molecule inhibitor of Bcl-2 with
Synonyms: Apogossypol; NSC736630
(+)-Apogossypol is a potent inhibitor of Bcl-2 family proteins; competing with the BH3 peptide-binding sites on Bcl-2, Bcl-XL, Mcl-1, Bcl-W, and Bcl-B, but not Bfl-1, with IC50s of 0.5 to 2 μM.
Synonyms: (S)-(+)-Gossypol acetic acid
(S)-Gossypol acetic acid is a inhibitor of Bcl-2, potently induce cell death in Jurkat cells overexpressing Bcl-2 (IC50, 18.1μM) or Bcl-xL (IC50, 22.9μM).
Synonyms: MR-29072
Pyridoclax is a potent Mcl-1 inhibitor with Kd value of 25 nM.
AZD-5991 is a potent and selective Mcl-1 inhibitor with an IC50 of 0.7 nM in FRET assay and a Kd of 0.17 nM in surface plasmon resonance (SPR) assay.
A-385358 is an inhibitor of Bcl-XL that enhances the in vitro cytotoxic activity of numerous chemotherapeutic agents (paclitaxel, etoposide, cisplatin, and doxorubicin) in several tumor cell lines.
FX1 is an inhibitor of the transcription factor B cell lymphoma 6 (BCL6) with IC50 value of ~35 μM.
AZD-4320 is a BH3 mimetic and dual Bcl-2/Bcl-XL inhibitor.
Synonyms: Marinopyrrole A
Marinopyrrole A, aslo known as Maritoclax, is a selective inhibitor of Mcl-1 with IC50 value of 10.1μM.
BT2 is a BCKDC kinase (BDK) inhibitor with an IC50 of 3.19 μM.
S63845 is a potent and selective myeloid cell leukemia 1 (MCL1) inhibitor with a Kd of 0.19 nM for human MCL1.
Out of stock
All 7 sizes
(R)-MIK665 is the less active enantiomer of MIK665. MIK665 is a special Mcl-1 inhibitor with an IC50 of 1.81 nM.
Synonyms: tapotoclax; tapotoclaxum.
AMG-176 is a potent, selective and orally bioavailable MCL-1 inhibitor, with a Ki of 0.13 nM.
Synonyms: BLC201
S55746 (BLC201) is a potent, orally active and selective BCL-2 inhibitor, with a Ki of 1.3 nM and a Kd of 3.9 nM. S55746 (BLC201) has antitumor activity with low toxicity.
Synonyms: S 64315
MIK665 (S-64315) is a special Mcl-1 inhibitor extracted from patent WO2016207225A1, compound Preparation 13, has an IC50 of 1.81 nM.
VU661013 is a MCL-1 Inhibitor Combined with Venetoclax Rescues Venetoclax Resistant Acute Myelogenous Leukemia.
Synonyms: EU-5346
ML311 is a potent and selective inhibitor of the Mcl-1/Bim interaction
Synonyms: Mcl1-inhibitor-2
Mcl1-IN-2 is a selective Mcl-1 inhibitor.
Synonyms: Mcl1-inhibitor-1
Mcl1-IN-1 is a potent and selective inhibitor of the apoptosis regulating proteins Mcl-1.
Mcl1-IN-8 (Comp8) is a Mcl-1-PUMA interface inhibitor, with a Ki of 0.3 μM. Mcl1-IN-8 (Comp8) exhibits dual activity on reduce PUMA-dependent apoptosis while deactivating Mcl-1-mediated anti-apoptosis in cancer cells.
Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) Inhibitor with an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM.
PROTAC Mcl1 degrader-1 (compound C3), a proteolysis targeting chimera (PROTAC), is a potently and selectively Mcl-1 inhibitor with an IC50 of 0.78 μM.
NPB is a specific and potent inhibitor of BAD phosphorylation at Ser99, with an IC50 of 0.41 μM.
Mcl1-IN-11 (Compound G) is a selective Mcl-1 inhibitor, less potent at Bcl-2, with Kis of 0.06 and 4.2 μM, respectively.